Results 1 to 10 of about 30,427 (262)
Distinctive detection of insulinoma using [18F]FB(ePEG12)12-exendin-4 PET/CT
Scientific Reports, 2021 Specifying the exact localization of insulinoma remains challenging due to the lack of insulinoma-specific imaging methods. Recently, glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging, especially positron emission tomography (PET), has emerged ...
T. Murakami +11 more
semanticscholar +2 more sources
Approach to the Patient: Insulinoma
Journal of Clinical Endocrinology and Metabolism, 2023 Insulinomas are hormone-producing pancreatic neuroendocrine neoplasms with an estimated incidence of 1 to 4 cases per million per year. Extrapancreatic insulinomas are extremely rare.
J. Hofland +4 more
semanticscholar +1 more source
Current Trends in Diagnosis, Treatment and Prognosis of Canine Insulinoma
Veterinary Sciences, 2022 Simple Summary Dogs can develop a tumour of the pancreas that produces too much insulin, which is called an ‘insulinoma’. These tumours cause signs such as collapse at exercise and very low blood sugar.
Floryne O. Buishand
semanticscholar +1 more source
The incidence of insulinoma in Western Sweden between 2002 and 2019
Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, 2022 Background Insulinoma is a rare pancreatic neuroendocrine neoplasm with an incidence of 0.7-4 cases per million/year. Because of its rarity, epidemiological studies on insulinoma are few and limited by small sample sizes.
E. Svensson +3 more
semanticscholar +1 more source
Veterinary Record Open, 2022 Background Insulinomas are the most common tumour of the endocrine pancreas in dogs. These malignant tumours have a high metastatic rate and limited chemotherapeutic options.
Sabina Sheppard-Olivares +9 more
semanticscholar +1 more source
Surgical Clinics of North America, 2009 Insulinoma is a rare neuroendocrine tumor with an incidence of 4 per 1 million persons per year, which may occur as a unifocal sporadic event in patients without an inherited syndrome or as a part of multiple endocrine neoplasia type 1. Key neuroglycopenic and hypoglycemic symptoms in conjunction with biochemical proof establish the diagnosis. Once the
Kimberly, Vanderveen, Clive, Grant
openaire +4 more sources
Long-term morbidity and mortality in patients diagnosed with an insulinoma
European Journal of Endocrinology, 2021 Objective Insulinomas are rare functional pancreatic neuroendocrine tumours. As previous data on the long-term prognosis of insulinoma patients are scarce, we studied the morbidity and mortality in the Finnish insulinoma cohort.
E. Peltola +15 more
semanticscholar +1 more source
Journal of Clinical Endocrinology and Metabolism, 2021 CONTEXT Insulinoma is the most common pancreatic functional neuroendocrine neoplasm, yet little information on recent clinical practice in patients with insulinoma, especially malignant insulinoma, is available. OBJECTIVE To clarify the characteristics
Kayo Ikeda Kurakawa +14 more
semanticscholar +1 more source
Value of 68Ga-DOTATOC and Carbidopa-Assisted 18F-DOPA PET/CT for Insulinoma Localization
Journal of Nuclear Medicine, 2021 Visual Abstract Our objective was to assess the value of 68Ga-DOTATOC and carbidopa-assisted 18F-fluorodihydroxyphenylalanine (18F-DOPA) in 21 hypoglycemic patients.
A. Imperiale +7 more
semanticscholar +1 more source